Polydiethylstilbestrol phosphate

Synthetic estrogen

Polydiethylstilbestrol phosphate
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number
PubChem
DrugBank
ChemSpider
KEGG

Polydiethylstilbestrol phosphate is a synthetic, nonsteroidal estrogen of the stilbestrol group, which was developed for medical use. It is a phosphate ester of diethylstilbestrol (DES), a compound that was widely used in the past for various estrogenic purposes.

Chemical structure and properties

Polydiethylstilbestrol phosphate is a polymer of diethylstilbestrol, where the phosphate group is attached to the hydroxyl groups of the diethylstilbestrol molecules. This modification increases the water solubility of the compound, making it suitable for intravenous administration. The chemical structure of polydiethylstilbestrol phosphate allows it to act as a prodrug, releasing active diethylstilbestrol upon metabolism in the body.

Chemical structure of Polydiethylstilbestrol phosphate

Pharmacology

As a prodrug of diethylstilbestrol, polydiethylstilbestrol phosphate exerts its effects by being converted into the active form in the body. Diethylstilbestrol is a potent estrogen that binds to estrogen receptors, leading to the activation of estrogen-responsive genes. This results in the promotion of female secondary sexual characteristics and the regulation of the menstrual cycle. The phosphate ester form allows for a more controlled release and distribution of the active drug.

Medical uses

Polydiethylstilbestrol phosphate was primarily used in the past for its estrogenic effects. It was indicated for the treatment of menopausal symptoms, such as hot flashes and vaginal atrophy, and for the prevention of osteoporosis in postmenopausal women. Additionally, it was used in the management of certain hormone-responsive cancers, such as prostate cancer and breast cancer.

Safety and side effects

The use of polydiethylstilbestrol phosphate, like other forms of diethylstilbestrol, has been associated with significant side effects. These include an increased risk of thromboembolic events, endometrial cancer, and breast cancer. Due to these risks, the use of diethylstilbestrol and its derivatives has been largely discontinued in favor of safer alternatives.

History

Diethylstilbestrol was first synthesized in the 1930s and was widely used throughout the mid-20th century. Polydiethylstilbestrol phosphate was developed as a more soluble form of the drug, allowing for different routes of administration. However, due to the adverse effects associated with diethylstilbestrol, its use has been largely phased out.

Related pages

• Diethylstilbestrol
• Estrogen
• Prodrug
• Hormone therapy